TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 31425966

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy (IC) followed by concurrent chemoradiotherapy (CCRT)
Number of subjects: 476

Group type: COMPARATOR
Intervention: Concurrent chemoradiotherapy (CCRT) alone
Number of subjects: 476
Study: 29415833

Group type: EXPERIMENTAL
Intervention: l-arginine (6 g/day for 7 days)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 24839047

Group type: EXPERIMENTAL
Intervention: Sublingual fentanyl orally disintegrating tablet
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 23816726

Group type: EXPERIMENTAL
Intervention: Eradication treatment for Helicobacter pylori infection
Number of subjects: 50
Study: 21820166

Group type: EXPERIMENTAL
Intervention: Text-message reminders sent to health workers' mobile phones on malaria case-management for 6 months
Number of subjects: 119

Group type: COMPARATOR
Intervention: No text-message reminders (Control group)
Number of subjects: 119
Study: 19399308

Group type: EXPERIMENTAL
Intervention: Certified Respiratory Educators (CREs)
Number of subjects: 198

Group type: COMPARATOR
Intervention: Physicians
Number of subjects: 198
Study: 16675511

Group type: EXPERIMENTAL
Intervention: Hypercapnia (50 mm Hg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Normocapnia (35 mm Hg)
Number of subjects: 10
Study: 14744521

Group type: EXPERIMENTAL
Intervention: Shown‐Discrepancy Group
Number of subjects: 0

Group type: COMPARATOR
Intervention: No‐Demonstration Group
Number of subjects: 0
Study: 11333069

Group type: EXPERIMENTAL
Intervention: Electroconvulsive therapy (ECT) with varying electrode placement and stimulus intensity; lorazepam PRN (3 mg/day) was allowed.
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: Electroconvulsive therapy (ECT) with unilateral or bilateral application.
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: Electroconvulsive therapy (ECT) for bipolar patients (BP I and BP II).
Number of subjects: 228
Study: 8979175

Group type: EXPERIMENTAL
Intervention: Protonics exercise regimen
Number of subjects: 60

Group type: COMPARATOR
Intervention: Established protocol
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 60
Study: 8507109

Group type: EXPERIMENTAL
Intervention: Total Parenteral Nutrition (TPN)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Regular oral diet (Control)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: TPN (1 patient with jejunum obtained)
Number of subjects: 13
Study: 2435356

Group type: EXPERIMENTAL
Intervention: Phenoxybenzamine 10 mg/day for 5 weeks
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 29452603

Group type: EXPERIMENTAL
Intervention: Desflurane (6% in 40% O2 and 60% air)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Sevoflurane (2% in 40% O2 and 60% air)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Comparison of nesfatin levels between groups
Number of subjects: 42
Study: 27274216

Group type: EXPERIMENTAL
Intervention: NAVA
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Edi catheter insertion
Number of subjects: 33
Study: 24698126

Group type: EXPERIMENTAL
Intervention: Local heat therapy (hot pack warmed to 50 °C)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo heat therapy (hot pack warmed to 37 °C)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Local heat therapy
Number of subjects: 66
Study: 23639030

Group type: EXPERIMENTAL
Intervention: Life storybook creation process (intervention group, n = 14)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Non-life storybook (control group, n = 12)
Number of subjects: 26
Study: 21234866

Group type: EXPERIMENTAL
Intervention: BCG plus prulifloxacin (600 mg single oral dose 6 hours after instillation)
Number of subjects: 43

Group type: COMPARATOR
Intervention: BCG alone
Number of subjects: 43
Study: 17535522

Group type: EXPERIMENTAL
Intervention: Single-sex physics classes
Number of subjects: 401

Group type: COMPARATOR
Intervention: Coeducational physics classes
Number of subjects: 401

Group type: COMPARATOR
Intervention: Mixed-sex classes
Number of subjects: 401
Study: 16402604

Group type: EXPERIMENTAL
Intervention: Causal analysis of coherence and transfer function between systolic pressure (SP) and RR interval variability in patients with neurally mediated syncope.
Number of subjects: 16

Group type: COMPARATOR
Intervention: Causal analysis of coherence and transfer function between systolic pressure (SP) and RR interval variability in control subjects.
Number of subjects: 16
Study: 12819631

Group type: EXPERIMENTAL
Intervention: Herbal ointment applied to affected joint(s) for 42 days
Number of subjects: 36

Group type: COMPARATOR
Intervention: Sham ointment applied to affected joint(s) for 42 days
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Herbal ointment
Number of subjects: 36
Study: 12411810

Group type: EXPERIMENTAL
Intervention: Thoracic epidural analgesia initiated prior to incision
Number of subjects: 157

Group type: COMPARATOR
Intervention: Thoracic epidural analgesia initiated at the time of rib approximation
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Women
Number of subjects: 157
Study: 9688748

Group type: EXPERIMENTAL
Intervention: Resistance Training (RT; 3 days/wk resistance training)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Combined Training (CT; 3 days/wk jogging and/or running + resistance training)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Endurance Training (ET; 3 days/wk jogging and/or running)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Resistance Training (RT)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Combined Training (CT)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Endurance Training (ET)
Number of subjects: 30
Study: 8061263

Group type: EXPERIMENTAL
Intervention: pipecuronium (0.15 mg/kg)
Number of subjects: 30

Group type: COMPARATOR
Intervention: doxacurium (0.08 mg/kg)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both interventions (pipecuronium and doxacurium)
Number of subjects: 30
Study: 2456424

Group type: EXPERIMENTAL
Intervention: Operation plus preoperative and postoperative therapy with cisplatin, vindesine, and bleomycin (n = 19)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Operation only (n = 20)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Patients responding to chemotherapy preoperatively
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Nonresponders to chemotherapy
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Patients receiving only operation
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Weight loss of less than 10%
Number of subjects: 39
Study: 30829209

Group type: EXPERIMENTAL
Intervention: Candicure (polyherbal formulation)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Fluconazole therapy (control drug)
Number of subjects: 150
Study: 28340904

Group type: EXPERIMENTAL
Intervention: AWARE (group-based motivational interviewing intervention)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 200
Study: 25966264

Group type: EXPERIMENTAL
Intervention: Ginkgo biloba tablets (GBT) 19.2 mg three times a day for 3 months along with conventional anti-platelet aggregation treatment
Number of subjects: 80

Group type: COMPARATOR
Intervention: Conventional treatment with 75 mg aspirin three times a day for 3 months
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Ginkgo biloba tablets (GBT)
Number of subjects: 80
Study: 23859768

Group type: EXPERIMENTAL
Intervention: Interactive multimedia program (viewing at least 4 options to discipline a child)
Number of subjects: 258

Group type: COMPARATOR
Intervention: Routine primary care with resident physician (control group)
Number of subjects: 258
Study: 22398345

Group type: EXPERIMENTAL
Intervention: Iyengar yoga program (twice-weekly classes for 8 weeks)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control group (usual daily routines)
Number of subjects: 38
Study: 19212259

Group type: EXPERIMENTAL
Intervention: Nitrous oxide
Number of subjects: 441
Study: 17127232

Group type: EXPERIMENTAL
Intervention: Irinotecan (CPT-11), leucovorin (LV), and 5-fluorouracil (5FU)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Leucovorin (LV) and 5-fluorouracil (5FU)
Number of subjects: 160
Study: 14713747

Group type: EXPERIMENTAL
Intervention: finasteride
Number of subjects: 18882

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 18882
Study: 11370751

Group type: EXPERIMENTAL
Intervention: Palatal plate therapy
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no palatal plate therapy)
Number of subjects: 20
Study: 9212478

Group type: EXPERIMENTAL
Intervention: Transdermal fentanyl (TDF)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Oral controlled-release morphine (MST)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 40
Study: 7962684

Group type: EXPERIMENTAL
Intervention: Clonazepam
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Alprazolam
Number of subjects: 43
Study: 3663878

Group type: EXPERIMENTAL
Intervention: Single dose of adinazolam (40 mg)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Steady-state dosing of adinazolam (final dose rates of 1, 2, and 3 mg h‐1)
Number of subjects: 8
Study: 30737889

Group type: EXPERIMENTAL
Intervention: Affected meridian acupuncture
Number of subjects: 428

Group type: EXPERIMENTAL
Intervention: Non-affected meridian acupuncture
Number of subjects: 428

Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 428

Group type: COMPARATOR
Intervention: Waiting-list control
Number of subjects: 428

Group type: EXPERIMENTAL
Intervention: Acupuncture (pooled groups)
Number of subjects: 428
Study: 29364091

Group type: EXPERIMENTAL
Intervention: Combination therapy of Lamivudine (LAM) and Adefovir Dipivoxil (ADV)
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: 12-week optimized therapy of Adefovir Dipivoxil (ADV) after Lamivudine (LAM)
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: 24-week optimized therapy of Adefovir Dipivoxil (ADV) after Lamivudine (LAM)
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Entecavir (ETV) monotherapy
Number of subjects: 127

Group type: COMPARATOR
Intervention: Combination therapy, 12-week optimized therapy, and ETV monotherapy
Number of subjects: 127
Study: 25530151

Group type: EXPERIMENTAL
Intervention: Cocoa flavanols (CF) 1.4-10.9 mg/kg bw
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Inorganic nitrate 0.1-10 mg/kg bw
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Nitrate (3 or 8.5 mg/kg bw) followed by CF (2.7 or 10.9 mg/kg bw)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Water (control)
Number of subjects: 15

Group type: COMPARATOR
Intervention: CF-free drink (micro- and macronutrient-matched)
Number of subjects: 15
Study: 24119879

Group type: EXPERIMENTAL
Intervention: Surgical reduction (Group A, n=36)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Fusion in situ (Group B, n=37)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Both groups (Group A and Group B)
Number of subjects: 73
Study: 21610559

Group type: EXPERIMENTAL
Intervention: High-volume wound infiltration with ropivacaine 0.2% with epinephrine (10 μg/mL)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Saline 0.9% (placebo)
Number of subjects: 120
Study: 19479528

Group type: EXPERIMENTAL
Intervention: Caring approximately Web (Web-based intervention)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Non-Web user group (Control)
Number of subjects: 103
Study: 16972834

Group type: EXPERIMENTAL
Intervention: Tramadol (2 mg.kg‐1 tramadol in 0.2 ml.kg‐1 saline)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Bupivacaine (0.2 ml.kg‐1 0.25% bupivacaine)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Intramuscular tramadol (2 mg.kg‐1 tramadol injected 20 minutes before end of surgery)
Number of subjects: 75
Study: 15163651

Group type: EXPERIMENTAL
Intervention: Fusidic acid
Number of subjects: 0

Group type: COMPARATOR
Intervention: Metronidazole
Number of subjects: 0
Study: 10908213

Group type: EXPERIMENTAL
Intervention: Bosentan (50, 150, and 300 mg administered at 2-hour intervals)
Number of subjects: 7
Study: 9156659

Group type: EXPERIMENTAL
Intervention: GM-CSF (molgramostim) 8 mg/kg/d for 14 days
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: GM-CSF (molgramostim)
Number of subjects: 40
Study: 7798818

Group type: EXPERIMENTAL
Intervention: Morphine slow release tablet (MST)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Morphine sulphate solution (MSS)
Number of subjects: 49
Study: 3521561

Group type: EXPERIMENTAL
Intervention: Timolol ophthalmic solution
Number of subjects: 40

Group type: COMPARATOR
Intervention: Vehicle of timolol (control)
Number of subjects: 40
Study: 29883597

Group type: EXPERIMENTAL
Intervention: Bilateral rTMS (1200 pulses at 20 Hz followed by 1200 pulses per session)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Unilateral right rTMS (2400 pulses at 20 Hz)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Bilateral rTMS
Number of subjects: 65
Study: 26932780

Group type: EXPERIMENTAL
Intervention: Autologous blood transfusion (ABT) device
Number of subjects: 229

Group type: COMPARATOR
Intervention: High-vacuum drainage
Number of subjects: 229

Group type: EXPERIMENTAL
Intervention: Retransfusion (among those who received it)
Number of subjects: 229
Study: 24678979

Group type: EXPERIMENTAL
Intervention: Evolocumab (420 mg) every 4 weeks
Number of subjects: 901

Group type: EXPERIMENTAL
Intervention: Evolocumab (420 mg) with background therapy of diet alone
Number of subjects: 901

Group type: EXPERIMENTAL
Intervention: Evolocumab (420 mg) with background therapy of atorvastatin 10 mg
Number of subjects: 901

Group type: EXPERIMENTAL
Intervention: Evolocumab (420 mg) with background therapy of atorvastatin 80 mg
Number of subjects: 901

Group type: EXPERIMENTAL
Intervention: Evolocumab (420 mg) with background therapy of atorvastatin 80 mg plus ezetimibe 10 mg
Number of subjects: 901

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 901
Study: 22948387

Group type: COMPARATOR
Intervention: Cefepime (CFPM, control)
Number of subjects: 255

Group type: EXPERIMENTAL
Intervention: Panipenem/betamiprom (PAPM/BP)
Number of subjects: 255

Group type: EXPERIMENTAL
Intervention: Meropenem (MEPM)
Number of subjects: 255

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin (CPFX)
Number of subjects: 255

Group type: EXPERIMENTAL
Intervention: Aminoglycosides (AGs)
Number of subjects: 255
Study: 20357810

Group type: EXPERIMENTAL
Intervention: Tele-education instruction (TI)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Classroom teaching (CT)
Number of subjects: 48
Study: 17451909

Group type: EXPERIMENTAL
Intervention: Model package inserts
Number of subjects: 1105

Group type: COMPARATOR
Intervention: Original package inserts
Number of subjects: 1105
Study: 15136775

Group type: EXPERIMENTAL
Intervention: Moderate intensity supervised aerobic exercise program (n = 15)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control group (n = 16)
Number of subjects: 31
Study: 11478556

Group type: EXPERIMENTAL
Intervention: Operative treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Taping (Conservative management)
Number of subjects: 0
Study: 9749682

Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 8147547

Group type: EXPERIMENTAL
Intervention: Low-dose dopamine (3 micrograms/kg per minute)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study: 3171029

Group type: EXPERIMENTAL
Intervention: Pamphlets only
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Nursing follow-up
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Trained volunteer follow-up
Number of subjects: 73

Group type: COMPARATOR
Intervention: Control group (patients on another medical floor)
Number of subjects: 73
Study: 31461862

Group type: EXPERIMENTAL
Intervention: Low glycemic‐index pulse‐based diet
Number of subjects: 6

Group type: COMPARATOR
Intervention: Typical hospital diet
Number of subjects: 6
Study: 29940914

Group type: EXPERIMENTAL
Intervention: Lifestyle advice alongside estimated 10-year risk of developing cancer presented in bar chart format
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Lifestyle advice alongside estimated 10-year risk of developing cancer presented in pictograph format
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Lifestyle advice alongside estimated 10-year risk of developing cancer presented in qualitative scale format
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Control group receiving cancer-specific lifestyle advice alone
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: All intervention groups
Number of subjects: 1000
Study: 26453814

Group type: EXPERIMENTAL
Intervention: QRS distortion in two or more leads (D2+)
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: QRS distortion in one lead (D1)
Number of subjects: 174

Group type: COMPARATOR
Intervention: No QRS distortion (D0)
Number of subjects: 174
Study: 24597469

Group type: EXPERIMENTAL
Intervention: Integrated Treatment (IT)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Treatment as usual (Control Group)
Number of subjects: 76
Study: 22026455

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (1111-6800 IU/day)
Number of subjects: 569

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 569
Study: 20565953

Group type: EXPERIMENTAL
Intervention: Docetaxel followed by anthracyclines (Arm A)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Drugs in reverse order (Arm B)
Number of subjects: 60
Study: 17407241

Group type: EXPERIMENTAL
Intervention: TNF-blocking drug
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Berlin method
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: SPARCC scoring system
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: ASspiMRI-a
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: All methods
Number of subjects: 30
Study: 15640607

Group type: EXPERIMENTAL
Intervention: Misoprostol 50 microg sublingually
Number of subjects: 160

Group type: COMPARATOR
Intervention: Misoprostol 50 microg vaginally
Number of subjects: 160
Study: 12523454

Group type: EXPERIMENTAL
Intervention: Experimental conditions (specifics not provided)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control conditions (specifics not provided)
Number of subjects: 0
Study: 10695094

Group type: EXPERIMENTAL
Intervention: amoxycillin/clavulanate 875/125 mg twice daily
Number of subjects: 324

Group type: COMPARATOR
Intervention: amoxycillin/clavulanate 500/125 mg three times daily
Number of subjects: 324
Study: 8620702

Group type: EXPERIMENTAL
Intervention: BAY u3405 (75 mg orally, twice a day for 2 weeks)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (oral, twice a day for 2 weeks)
Number of subjects: 12
Study: 2008870

Group type: EXPERIMENTAL
Intervention: Monounsaturated fatty acid (MUFA) diet
Number of subjects: 26

Group type: COMPARATOR
Intervention: Polyunsaturated fatty acid (PUFA) diet
Number of subjects: 26
Study: 6285241

Group type: EXPERIMENTAL
Intervention: Ifosfamide monotherapy
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Ifosfamide + CCNU
Number of subjects: 55

Group type: COMPARATOR
Intervention: Symptomatic therapy (control group)
Number of subjects: 55
Study: 29986592

Group type: EXPERIMENTAL
Intervention: Workplace intervention targeting sedentary behavior
Number of subjects: 632

Group type: EXPERIMENTAL
Intervention: Survey sent to nonparticipants (N = 57)
Number of subjects: 632

Group type: EXPERIMENTAL
Intervention: Modifications developed to overcome participation barriers
Number of subjects: 632
Study: 27830365

Group type: EXPERIMENTAL
Intervention: Haloperidol (5 mg) administered daily during postoperative days 0-5
Number of subjects: 201

Group type: COMPARATOR
Intervention: Control group (no haloperidol)
Number of subjects: 201
Study: 24977456

Group type: EXPERIMENTAL
Intervention: Behavioral weight loss intervention
Number of subjects: 40

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 40
Study: 23403068

Group type: EXPERIMENTAL
Intervention: Linagliptin (5 mg/day)
Number of subjects: 2258

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2258

Group type: EXPERIMENTAL
Intervention: Linagliptin
Number of subjects: 2258
Study: 22000309

Group type: EXPERIMENTAL
Intervention: Valproate (20 mg/kg)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Phenytoin (20 mg/kg)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Valproate (20 mg/kg) with diazepam
Number of subjects: 100

Group type: COMPARATOR
Intervention: Phenytoin (20 mg/kg) with diazepam
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Valproate only
Number of subjects: 100

Group type: COMPARATOR
Intervention: Phenytoin only
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Valproate and Phenytoin
Number of subjects: 100
Study: 19016706

Group type: EXPERIMENTAL
Intervention: Tacalcitol ointment plus sunlight exposure
Number of subjects: 80

Group type: COMPARATOR
Intervention: Vehicle (placebo) ointment plus sunlight exposure
Number of subjects: 80
Study: 17442583

Group type: EXPERIMENTAL
Intervention: Adhesive paper-tape closure
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sutured closure
Number of subjects: 60
Study: 15574550

Group type: EXPERIMENTAL
Intervention: MPT (Microcuff pediatric tracheal tube) with baseline cuff pressure set to sealing pressure (10 cm H(2)O)
Number of subjects: 30

Group type: COMPARATOR
Intervention: PVC (standard polyvinyl chloride cuff) with baseline cuff pressure 20 cm H(2)O
Number of subjects: 30

Group type: COMPARATOR
Intervention: MPT (Microcuff pediatric tracheal tube) with baseline cuff pressure 20 cm H(2)O
Number of subjects: 30
Study: 11422014

Group type: EXPERIMENTAL
Intervention: Sinistrin (2500 mg, intravenous)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: p-Aminohippuric acid (PAH; 440 mg, intravenous)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Rac-pindolol (15 mg, oral)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: S-pindolol (15 mg, oral)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Fluconazole (100 mg, oral)
Number of subjects: 12
Study: 10772561

Group type: EXPERIMENTAL
Intervention: H-ELISA
Number of subjects: 1332
Study: 8536521

Group type: EXPERIMENTAL
Intervention: Intravenous infusion of CCK (24 pmol/kg/hr)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 10